Header cover image

Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedMar 14, 2025
DataAggregated Company Financials
Companies11
  • 7D7.4%
  • 3M13.5%
  • 1Y16.9%
  • YTD19.1%

The Pharma industry is up 4.6% in the last week, with Memphis Pharmaceuticals & Chemical Industries up 35%. This means that the industry has gained 16% over the past year. Looking forward, earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 14 Mar 2025ج.م28.7bج.م26.2bج.م2.8b7.3x10.1x1.1x
Sun, 09 Feb 2025ج.م24.9bج.م23.8bج.م2.4b9.1x10.4x1x
Tue, 07 Jan 2025ج.م23.6bج.م23.7bج.م2.4b8.7x9.9x1x
Thu, 05 Dec 2024ج.م23.3bج.م23.2bج.م2.3b7x10.1x1x
Sat, 02 Nov 2024ج.م24.1bج.م22.0bج.م2.2b6.8x11.2x1.1x
Mon, 30 Sep 2024ج.م21.9bج.م22.1bج.م2.1b6.5x10.2x1x
Wed, 28 Aug 2024ج.م19.1bج.م22.1bج.م2.4b5.6x7.9x0.9x
Fri, 26 Jul 2024ج.م18.9bج.م21.3bج.م2.5b5x7.7x0.9x
Sun, 23 Jun 2024ج.م18.0bج.م20.8bج.م2.3b7x7.9x0.9x
Tue, 21 May 2024ج.م18.5bج.م20.1bج.م1.8b7.8x10.2x0.9x
Thu, 18 Apr 2024ج.م21.7bج.م19.3bج.م1.8b8.5x12.3x1.1x
Sat, 16 Mar 2024ج.م22.8bج.م18.9bج.م2.2b9.5x10.2x1.2x
Mon, 12 Feb 2024ج.م21.5bج.م18.5bج.م2.4b9.5x9x1.2x
Wed, 10 Jan 2024ج.م18.7bج.م16.0bج.م2.2b7.1x8.6x1.2x
Fri, 08 Dec 2023ج.م19.4bج.م16.5bج.م2.2b9.1x9x1.2x
Sun, 05 Nov 2023ج.م15.2bج.م15.4bج.م1.9b6.5x7.8x1x
Tue, 03 Oct 2023ج.م14.0bج.م15.3bج.م1.9b5.6x7.3x0.9x
Thu, 31 Aug 2023ج.م13.9bج.م15.7bج.م2.1b7.2x6.7x0.9x
Sat, 29 Jul 2023ج.م13.4bج.م15.6bج.م2.1b6.9x6.4x0.9x
Mon, 26 Jun 2023ج.م13.8bج.م16.2bج.م2.2b5.4x6.2x0.9x
Wed, 24 May 2023ج.م13.7bج.م16.2bج.م2.4b4.3x5.7x0.8x
Fri, 21 Apr 2023ج.م14.5bج.م16.2bج.م2.4b5.2x6x0.9x
Sun, 19 Mar 2023ج.م13.4bج.م15.7bج.م2.3b5.3x5.8x0.9x
Tue, 14 Feb 2023ج.م14.9bج.م15.6bج.م2.3b5.3x6.5x1x
Thu, 12 Jan 2023ج.م15.0bج.م15.6bج.م2.3b5.4x6.6x1x
Sat, 10 Dec 2022ج.م15.1bج.م15.6bج.م2.3b4.9x6.6x1x
Mon, 07 Nov 2022ج.م12.9bج.م15.1bج.م2.2b5.1x6x0.9x
Wed, 05 Oct 2022ج.م12.6bج.م15.1bج.م2.2b4.7x5.8x0.8x
Fri, 02 Sep 2022ج.م13.0bج.م14.3bج.م2.0b6.1x6.4x0.9x
Sun, 31 Jul 2022ج.م12.4bج.م14.1bج.م1.9b5.6x6.4x0.9x
Tue, 28 Jun 2022ج.م11.9bج.م14.1bج.م1.9b5.6x6.2x0.8x
Thu, 26 May 2022ج.م11.8bج.م11.9bج.م1.7b5.6x7.1x1x
Sat, 23 Apr 2022ج.م12.3bج.م11.8bج.م1.7b5.5x7.5x1x
Mon, 21 Mar 2022ج.م12.7bج.م13.7bج.م1.8b6.5x6.9x0.9x
Price to Earnings Ratio

6.9x


Total Market Cap: ج.م12.7bTotal Earnings: ج.م1.8bTotal Revenue: ج.م13.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7.8x202320242025
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 9.9x which is higher than its 3-year average PE of 7.8x.
  • The 3-year average PS ratio of 0.96x is lower than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 15% per year over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare industry?

EG Market1.66%
Healthcare7.14%
Pharma7.43%
Pharma7.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)Eج.م4.6310.0%
+ج.م631.5m
63.6%PE18x
MPCI Memphis Pharmaceuticals & Chemical Industriesج.م83.9639.4%
+ج.م539.9m
-18.5%PE5.1x
BIOC GlaxoSmithKlineEج.م40.4010.0%
+ج.م305.7m
22.1%PE19.4x
PHAR Egyptian International Pharmaceutical Industriesج.م50.203.5%
+ج.م252.9m
3.5%PE6.8x
MIPH MINAPHARM Pharmaceuticalsج.م174.436.9%
+ج.م125.0m
-32.9%PS0.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PHAR

ج.م50.20

Egyptian International Pharmaceutical Industries

7D

3.5%

1Y

3.5%

BIOC

ج.م40.40

GlaxoSmithKlineE

7D

10.0%

1Y

22.1%

CPCI

ج.م134.74

Kahira Pharmaceuticals & Chemical Industries

7D

3.7%

1Y

71.8%

ADCI

ج.م149.95

Arab Drug

7D

1.5%

1Y

77.0%

MIPH

ج.م174.43

MINAPHARM Pharmaceuticals

7D

6.9%

1Y

-32.9%